Smart Thalassaemia Diagnostic System


IoT-enabled Testing Device

AI-enabled Decision Suppport


Highest % of β-Thalassaemia


In south-East-Asian countries. Pakistan is one of the few with highest prevalence.


Huge Socio-economic burden

USD 203 Million approx. direct & indirect treatment cost per year per 100k patients (Pak).


0.5%–0.9% of all children deaths from LMICs

β-Thalassemia results in approx. 50,000–100,000 deaths annually around the globe.







Thalassaemia

Thalassaemia is an inherited blood-related disorder in which one or more globin chains are either not produced at all or are produced at a reduced rate.

Thalassaemia Minor

For a couple, if one of the partners carry the abnormal thalassaemia gene, there's a 50% risk of giving birth to 'Thalassaemia Minor' children.

Thalassaemia Major

For a couple, if both of the partners carry the abnormal thalassaemia gene, there's a 50% risk of giving birth to 'Thalassaemia Minor' children and 25% risk of giving birth to 'Thalassaemia Major' children.

Screening

In Pakistan, Punjab thalassaemia prevention program is active but the initiative hasn’t met the desired outcome. The screening devices are expensive, high maintenance and require expert handling. Diagnosis is expert-intensive and reports are often delayed with patients travelling from far areas to get tested.

Prevalence of Thalassaemia

250

Million Carriers

300000

New cases/year

10

Million Carriers

10000

New cases/year

Research

ThalaScreen is carrying out cutting-edge research in collaboration with expert haematologists to diagnose for Thalassaemia with advanced AI-algorithms. Our research objective is to prevent the spread of this national-level disease through an innovative digital thalassaemia diagnostic system.

AI-enabled

IoT-enabled

Portable

Easy Maintenance

Cloud Database

User-friendly

Collaborations

Our research collaborators include Khyber Medical College & University, Lady Reading Hospital, Hayatabad Medical Complex, KP Health Department, Rehman Medical Institute, Peshawar, Pakistan.

Team

ThalaScreen's team comprises of AI experts, biomedical, electronics and cloud engineers, software developers and haematologists.



Dr. Muhammad Salman Khan

Founder

Contact

For any type of queries and/or pre-order requests, please contact with the information provided.

Call:

+92 316 9595140

LinkedIn:

ThalaScreen